10:26 AM EDT, 05/22/2024 (MT Newswires) -- Achilles Therapeutics ( ACHL ) said Wednesday it has entered into a research collaboration with Arcturus Therapeutics ( ARCT ) to evaluate self-amplifying mRNA personalized cancer vaccines targeting clonal neoantigens.

Under the partnership, Achilles will integrate its tumor-targeting technology with Arcturus' sa-mRNA platform, the biopharmaceutical company said.

Financial terms of the collaboration weren't disclosed.

Price: 0.92, Change: -0.03, Percent Change: -2.72